Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Pick the closest fit
Clinical Trial Outcomes with Monotherapy The REDEFINE 1 trial demonstrated that cagrilintide monotherapy at the 4.5 mg maintenance dose produced mean body weight reductions of approximately 10.8% from baseline after 32 weeks of treatment [4]
Purity tested Endotoxin tested Heavy metals tested In stock Batch-level quality proof Every research peptide is supplied as a sealed, clearly labelled vial
Diagnosis obscured In the situation of B12 deficiency, for instance, in the diagnostic process, theres only one chance to make a first impression
What BPC-157 specifications are available before checkout
Products are compounded by a licensed pharmacy
US$ 28.29
US$ 20.08
US$ 29.32
